- Home
- PHAR vs THR Comparison
PHAR vs THR Comparison
Compare PHAR & THR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- THR
- Stock Information
- Founded
- PHAR 1988
- THR 1954
- Country
- PHAR Netherlands
- THR United States
- Employees
- PHAR N/A
- THR N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- THR Industrial Machinery/Components
- Sector
- PHAR Health Care
- THR Energy
- Exchange
- PHAR Nasdaq
- THR Nasdaq
- Market Cap
- PHAR 951.7M
- THR 878.9M
- IPO Year
- PHAR N/A
- THR 2011
- Fundamental
- Price
- PHAR $14.34
- THR $26.17
- Analyst Decision
- PHAR Strong Buy
- THR
- Analyst Count
- PHAR 3
- THR 0
- Target Price
- PHAR $30.00
- THR N/A
- AVG Volume (30 Days)
- PHAR 14.9K
- THR 243.4K
- Earning Date
- PHAR 10-23-2025
- THR 11-06-2025
- Dividend Yield
- PHAR N/A
- THR N/A
- EPS Growth
- PHAR N/A
- THR 9.96
- EPS
- PHAR N/A
- THR 1.58
- Revenue
- PHAR $339,836,000.00
- THR $491,979,000.00
- Revenue This Year
- PHAR $17.44
- THR $2.56
- Revenue Next Year
- PHAR $8.46
- THR $6.31
- P/E Ratio
- PHAR N/A
- THR $16.80
- Revenue Growth
- PHAR 22.44
- THR N/A
- 52 Week Low
- PHAR $7.31
- THR $23.05
- 52 Week High
- PHAR $17.08
- THR $33.25
- Technical
- Relative Strength Index (RSI)
- PHAR 50.39
- THR 44.63
- Support Level
- PHAR $14.22
- THR $26.27
- Resistance Level
- PHAR $16.29
- THR $27.97
- Average True Range (ATR)
- PHAR 0.50
- THR 0.73
- MACD
- PHAR -0.13
- THR -0.08
- Stochastic Oscillator
- PHAR 37.30
- THR 0.00
About PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.
About THR Thermon Group Holdings Inc.
Thermon Group Holdings Inc is a United States-based company that provides engineered industrial process heating solutions for process industries. It offers a full suite of products (heating units, electrode and gas-fired boilers, heating cables, industrial heating blankets and related products, temporary power solutions and tubing bundles), services (engineering, installation and maintenance services) and software (design optimization and wireless and network control systems) required to deliver comprehensive solutions to some of the world's Large and most complex projects. Its products and services include a wide range of electric heat tracing cables, steam heating solutions, controls, monitoring and software, instrumentation, project services, industrial heating and filtration solutions.